Tectonic Therapeutics TECX Common stock issuance for private placement
Common stock issuance for private placement at other companies
Other financials
Where this comes from
Reported directly by Tectonic Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfPrivatePlacement.
The official record: Tectonic Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tectonic Therapeutics's common stock issuance for private placement.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tectonic Therapeutics's common stock issuance for private placement?
- Tectonic Therapeutics (TECX) reported common stock issuance for private placement of $0 in Q1 2026.
- How has Tectonic Therapeutics's common stock issuance for private placement changed year-over-year?
- Tectonic Therapeutics's common stock issuance for private placement decreased by 100.0% year-over-year, from $177.27M to $0.
- What does common stock issuance for private placement mean?
- Reflects the total cash inflows generated from the sale of equity securities directly to private investors rather than through public markets. This is a primary source of capital for biotechnology companies to fund research and development activities. High levels of proceeds indicate strong investor confidence and provide necessary liquidity for long-term drug discovery programs.